REGENXBIO Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Regenxbio Inc. (RGNX) PT Raised to $40 at Stifel
March 7, 2024 10:39 AM ESTStifel analyst Annabel Samimy raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $40.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy on RGNX and raise TP to $40 after another meaningful RGX-202 update from the AFFINITY-DUCHENNE Ph.1/2... More
